Press Releases
Swing Therapeutics Closes $10.3M Series A Funding Round
Swing Therapeutics, a digital therapeutics company developing evidence-backed treatments for autoimmune and chronic pain conditions, today announced that it has…
Read the ArticleNews and Resources
Articles and announcements from Swing
Press Releases
Introducing Stanza
Today marks an important milestone at Swing Therapeutics: Stanza, the first prescription digital therapy for fibromyalgia patients, is now commercially…
Read the Article
Press Releases
Swing Therapeutics Receives FDA Breakthrough Device Designation
Swing Therapeutics announced today that the FDA has granted Breakthrough Device Designation to the company’s digital therapeutic for the management…
Read the Article